10 likes | 105 Views
VEGF. CXCL8. 786-O. Untreated. Untreated. 1.5. BVZ. BVZ. **. 1.0. ng/ml.10 6 cells. ng/ml.10 6 cells. 0.5. ***. ***. 0. 1 day. 1 week. 1 day. 1 week. RCC4. 1.5. 5. 1.0. 4. ng/ml.10 6 cells. ng/ml.10 6 cells. 3. 2. 0.5. 1. 1 day. 1 week. 1 day. 1 week. 0. 0.
E N D
VEGF CXCL8 786-O Untreated Untreated 1.5 BVZ BVZ ** 1.0 ng/ml.106 cells ng/ml.106 cells 0.5 *** *** 0 1 day 1 week 1 day 1 week RCC4 1.5 5 1.0 4 ng/ml.106 cells ng/ml.106 cells 3 2 0.5 1 1 day 1 week 1 day 1 week 0 0 RCC10 1.5 ng/ml.106 cells ng/ml.106 cells 1.0 0.5 1 day 1 week 1 day 1 week Caki-2 0 1.5 1.0 ng/ml.106 cells ng/ml.106 cells 0.5 ** 0 1 day 1 week 1 day 1 week Grépin et al. Supplementary Figure 1